VERTEX PHARMACEUTICALS INC / MA Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $1.09 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2015-02-13
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2013-09-30 was $410.00K, a 6.49% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2013-06-30 was $342.00K, a 18.18% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2013-03-31 was $342.00K, a 25.65% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2012-12-31 was $231.00K, a 32.06% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2012 was $1.49M, a 102.71% increase from fiscal 2011.
- VERTEX PHARMACEUTICALS INC / MA noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2011 was $737.00K.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month |
|---|---|---|---|---|
| 2013-09-30 | $410.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $752.00K derived: sum of 2 quarters · filed 2014-11-06 | $1.09M 10-Q · filed 2014-11-06 | $1.32M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $342.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $684.00K 10-Q · filed 2014-07-31 | $915.00K derived: sum of 3 quarters · filed 2015-02-13 | $1.30M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $342.00K 10-Q · filed 2014-05-05 | $573.00K derived: sum of 2 quarters · filed 2015-02-13 | $958.00K derived: sum of 3 quarters · filed 2015-02-13 | $1.38M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $616.00K derived: sum of 2 quarters · filed 2015-02-13 | $1.03M derived: sum of 3 quarters · filed 2015-02-13 | $1.49M 10-K · filed 2015-02-13 |
| 2012-09-30 | $385.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $803.00K derived: sum of 2 quarters · filed 2013-11-07 | $1.26M 10-Q · filed 2013-11-07 | $1.60M derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-06-30 | $418.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $878.00K 10-Q · filed 2013-08-02 | $1.22M derived: sum of 3 quarters · filed 2014-02-11 | |
| 2012-03-31 | $460.00K 10-Q · filed 2013-05-08 | $800.00K derived: sum of 2 quarters · filed 2014-02-11 | ||
| 2011-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $737.00K 10-K · filed 2014-02-11 | ||
| 2011-09-30 | $397.00K 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |